Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity
- DOI
- 10.62347/hfgx2343
- Published
- 2026
- Container
- American Journal of Cancer Research
- Publisher
- e-Century Publishing Corporation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.62347/hfgx2343,
title = {Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity},
author = {Liping Bai and Xueyan Yang and Lixian Bai and Zhongkun Ren and Hong Gong and Yinghui Zhang and Han Chen and Zhijian Ma},
year = {2026},
journal = {American Journal of Cancer Research},
doi = {10.62347/hfgx2343},
url = {https://doi.org/10.62347/hfgx2343}
}RIS
TY - JOUR TI - Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity AU - Liping Bai AU - Xueyan Yang AU - Lixian Bai AU - Zhongkun Ren AU - Hong Gong AU - Yinghui Zhang AU - Han Chen AU - Zhijian Ma PY - 2026 JO - American Journal of Cancer Research DO - 10.62347/hfgx2343 UR - https://doi.org/10.62347/hfgx2343 ER -
APA
Bai, L., Yang, X., Bai, L., Ren, Z., Gong, H., Zhang, Y., Chen, H., & Ma, Z. (2026). Targeting FAM64A: a promising strategy to halt liver cancer angiogenesis and enhance immunity. American Journal of Cancer Research. https://doi.org/10.62347/hfgx2343
Source records
- crossref · retrieved 2026-09-26T00:06:24.472Z